Science · 1 views

Small-molecule switches put therapeutic CRISPR editing under on-demand control in living tissues

In a study published in Science Translational Medicine, a team of researchers led by Dr.

Source Phys.org AI Summary Updated 2h 03m ago

Story intelligence Beta

Freshness Fresh Updated 2h 03m ago

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~58 words

AI Summary

In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences developed PRINCE and Little Prince, dual small-molecule-controlled genome editing systems that allow CRISPR activity to be switched on by drug inducers and kept largely silent in their absence.

Read full article on PHYS

AI summaries can be wrong sometimes—always verify important details using the source article.